Literature DB >> 16552989

Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations.

Minehiro Gotoh1, Chang Li, Mariko Yatoh, Akihisa Iguchi, Yoshifumi Hirooka.   

Abstract

OBJECTIVE: Serum uric acid concentrations in diabetics are well known to be significantly lower than those in non-diabetic subjects, due to increased its urinary clearance. Serum 1,5-anhydroglucitol concentrations are also specifically decreased in diabetics through the increased urinary excretion. To gain an insight into the idea that a common mechanism might be possible to work in reducing these serum substances, this study was conducted.
METHODS: A total of 121 type 2 diabetic patients, 76 males and 45 females, were studied. Multiple regression analysis was performed to determine the independent association between potential predictor variables (mean blood pressure, body mass index, fasting plasma glucose, glycosylated hemoglobin A1c, serum fructosamine, serum 1,5-anhydroglucitol, serum creatinine, serum total cholesterol, and serum triglycerides) and serum uric acid concentrations as the dependent variable.
RESULTS: In the male subjects, serum 1,5-anhydroglucitol, serum creatinine and body mass index were the variables independently related to serum uric acid concentrations. In the female subjects, serum 1,5-anhydroglucitol and serum creatinine were the variables independently related to serum uric acid concentrations.
CONCLUSION: Considering the glucosuria-related urinary excretion of 1,5-anhydroglucitol, a close positive association between serum uric acid and 1,5-anhydroglucitol concentrations strongly supports the idea that the reduction in serum uric acid concentrations is mediated by urinary glucose excretion in diabetics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16552989

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  3 in total

1.  The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan.

Authors:  Jianmin Yang; Zhendong Liu; Cheng Zhang; Yingxin Zhao; Shangwen Sun; Shujian Wang; Yuxia Zhao; Yun Zhang; Jifu Li; Fanghong Lu
Journal:  Rheumatol Int       Date:  2012-12-15       Impact factor: 2.631

2.  Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.

Authors:  Motoshi Ouchi; Kenzo Oba; Kohei Kaku; Hideki Suganami; Akihiro Yoshida; Yasunori Fukunaka; Promsuk Jutabha; Asuka Morita; Naoyuki Otani; Keitaro Hayashi; Tomoe Fujita; Tatsuya Suzuki; Masahiro Yasutake; Naohiko Anzai
Journal:  Diabetes Obes Metab       Date:  2018-01-08       Impact factor: 6.577

3.  Correlation of Serum 1,5-AG with Uric Acid in Type 2 Diabetes Mellitus with Different Renal Functions.

Authors:  Kai Zhang; Bizhen Xue; Yuexing Yuan; Yao Wang
Journal:  Int J Endocrinol       Date:  2019-03-06       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.